Lieve Machtel Nckx

Title: Lieve Machtel Nckx: Innovator in Antibiotic Resistance Detection

Introduction

Lieve Machtel Nckx is a prominent inventor based in Gullegem, Belgium. She has made significant contributions to the field of microbiology, particularly in the detection of antibiotic resistance in Mycobacterium species. Her innovative work has the potential to enhance diagnostic methods and improve treatment strategies for infections caused by these bacteria.

Latest Patents

Lieve Machtel Nckx holds a patent for a method designed to detect the antibiotic resistance spectrum of Mycobacterium species. This method involves several steps, including the release, isolation, or concentration of polynucleic acids from a sample, amplification of antibiotic resistance genes, hybridization with specific gene probes, and detection of the resulting hybrids. The process ultimately infers the antibiotic resistance spectrum and identifies the Mycobacterium species involved.

Career Highlights

Lieve Machtel Nckx is associated with Innogenetics N.V., a company known for its advancements in genetic testing and diagnostics. Her work at Innogenetics has allowed her to collaborate with other experts in the field, furthering research and development in antibiotic resistance detection.

Collaborations

Some of her notable coworkers include Hans De Beenhouwer and Rudi Rossau. Their collaborative efforts contribute to the innovative environment at Innogenetics, fostering advancements in medical diagnostics.

Conclusion

Lieve Machtel Nckx's contributions to the detection of antibiotic resistance in Mycobacterium species highlight her role as an influential inventor in the field of microbiology. Her patent and work at Innogenetics demonstrate her commitment to improving healthcare through innovative solutions.